Complement Factor C7 Contributes to Lung Immunopathology Caused by Mycobacterium tuberculosis

Mycobacterium tuberculosis (MTB) remains a significant global health burden despite the availability of antimicrobial chemotherapy. Increasing evidence indicates a critical role of the complement system in the development of host protection against the bacillus, but few studies have specifically explored the function of the terminal complement factors. Mice deficient in complement C7 and wild-type C57BL/6 mice were aerosol challenged with MTB Erdman and assessed for bacterial burden, histopathology, and lung cytokine responses at days 30 and 60 post-infection. Macrophages isolated from C7 −/− and wild-type mice were evaluated for MTB proliferation and cytokine production. C7 −/− mice had significantly less liver colony forming units (CFUs) at day 30; no differences were noted in lung CFUs. The C7 deficient mice had markedly reduced lung occlusion with significantly increased total lymphocytes, decreased macrophages, and increased numbers of CD4+ cells 60 days post-infection. Expression of lung IFN-γ and TNF-α was increased at day 60 compared to wild-type mice. There were no differences in MTB-proliferation in macrophages isolated from wild-type and knock-out mice. These results indicate a role for complement C7 in the development of MTB induced immunopathology which warrants further investigation.

[1]  Devin R. Lindsey,et al.  A defect in the synthesis of Interferon-γ by the T cells of Complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis. , 2011, Tuberculosis.

[2]  K. J. Welsh,et al.  Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen. , 2011, Tuberculosis.

[3]  R. Hunter,et al.  Lactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response. , 2010, Translational research : the journal of laboratory and clinical medicine.

[4]  W. Bishai,et al.  Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view , 2010, Cellular microbiology.

[5]  A. van der Ende,et al.  Complement factor 7 gene mutations in relation to meningococcal infection and clinical recurrence of meningococcal disease. , 2010, Molecular immunology.

[6]  G. Kaplan,et al.  Advances in immunotherapy for tuberculosis treatment. , 2009, Clinics in chest medicine.

[7]  A. Krarup,et al.  Multiple routes of complement activation by Mycobacterium bovis BCG. , 2008, Molecular immunology.

[8]  R. Hunter,et al.  A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response. , 2008, Microbiology.

[9]  M. Braun,et al.  Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a. , 2008, Molecular immunology.

[10]  S. Kaufmann,et al.  Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis , 2007, Proceedings of the National Academy of Sciences.

[11]  S. Jolles,et al.  Current strategies in TB immunotherapy. , 2007, Current molecular medicine.

[12]  E. Reis,et al.  Complement components, regulators and receptors are produced by human monocyte-derived dendritic cells. , 2007, Immunobiology.

[13]  J. Atkinson,et al.  T-cell regulation: with complements from innate immunity , 2007, Nature Reviews Immunology.

[14]  B. Morgan,et al.  Cutting Edge: Murine CD59a Modulates Antiviral CD4+ T Cell Activity in a Complement-Independent Manner1 , 2005, The Journal of Immunology.

[15]  R. Hunter,et al.  Requisite Role for Complement C5 and the C5a Receptor in Granulomatous Response to Mycobacterial Glycolipid Trehalose 6,6′‐Dimycolate , 2005, Scandinavian journal of immunology.

[16]  J. Ellner,et al.  Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. , 2005, The Journal of infectious diseases.

[17]  Shin-Il Kim,et al.  Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship. , 2004, Clinical immunology.

[18]  J. Köhl,et al.  The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. , 2004, Molecular immunology.

[19]  John L. Johnson,et al.  A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis , 2004, AIDS.

[20]  M. Gadjeva,et al.  Myeloid C3 Determines Induction of Humoral Responses to Peripheral Herpes Simplex Virus Infection 1 , 2003, The Journal of Immunology.

[21]  John D Lambris,et al.  Complement Component 3 Is Required for Optimal Expansion of CD8 T Cells During a Systemic Viral Infection1 , 2003, The Journal of Immunology.

[22]  D. Corry,et al.  Absence of the Complement Anaphylatoxin C3a Receptor Suppresses Th2 Effector Functions in a Murine Model of Pulmonary Allergy1 , 2002, The Journal of Immunology.

[23]  R. Hunter,et al.  Influence of trehalose 6,6'-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. , 2002, Microbiology.

[24]  M. Bachmann,et al.  Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection , 2002, Nature Medicine.

[25]  J. Bower,et al.  Role of Complement in Mycobacterium avium Pathogenesis: In Vivo and In Vitro Analyses of the Host Response to Infection in the Absence of Complement Component C3 , 2001, Infection and Immunity.

[26]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[27]  Rick A. Wetsel,et al.  Cutting Edge: The Absence of C3 Demonstrates a Role for Complement in Th2 Effector Functions in a Murine Model of Pulmonary Allergy1 , 2001, The Journal of Immunology.

[28]  C. Jagannath,et al.  A Role for Complement C5 in Organism Containment and Granulomatous Response during Murine Tuberculosis , 2001, Scandinavian journal of immunology.

[29]  C. Sohaskey,et al.  Nonreplicating persistence of mycobacterium tuberculosis. , 2001, Annual review of microbiology.

[30]  R. Hunter,et al.  Hypersusceptibility of A/J Mice to Tuberculosis is in Part Due to a Deficiency of the Fifth Complement Component (C5) , 2000, Scandinavian journal of immunology.

[31]  A. Rao,et al.  Molecular aspects of T-cell differentiation. , 2000, British medical bulletin.

[32]  E. Peerschke,et al.  Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. , 1994, Journal of immunology.

[33]  E. Shevach,et al.  CD59 functions as a signal-transducing molecule for human T cell activation. , 1991, Journal of immunology.

[34]  M. Horwitz,et al.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.

[35]  G. Hetland,et al.  Human Alveolar Macrophages Synthesize the Functional Alternative Pathway of Complement and Active C5 and C9 in Vitro , 1986, Scandinavian journal of immunology.

[36]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .